nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoclopramide—DRD2—alcohol dependence	0.452	1	CbGaD
Metoclopramide—CHRM1—Citalopram—alcohol dependence	0.142	0.748	CbGbCtD
Metoclopramide—CYP2D6—Citalopram—alcohol dependence	0.0478	0.252	CbGbCtD
Metoclopramide—CYP17A1—seminiferous tubule of testis—alcohol dependence	0.0135	0.216	CbGeAlD
Metoclopramide—Lassitude—Disulfiram—alcohol dependence	0.0116	0.085	CcSEcCtD
Metoclopramide—Torticollis—Acamprosate—alcohol dependence	0.00472	0.0345	CcSEcCtD
Metoclopramide—Autonomic nervous system imbalance—Citalopram—alcohol dependence	0.00403	0.0295	CcSEcCtD
Metoclopramide—HTR4—adrenal cortex—alcohol dependence	0.00402	0.0641	CbGeAlD
Metoclopramide—Hyperprolactinaemia—Citalopram—alcohol dependence	0.00283	0.0207	CcSEcCtD
Metoclopramide—Torticollis—Citalopram—alcohol dependence	0.00283	0.0207	CcSEcCtD
Metoclopramide—HTR3A—nerve—alcohol dependence	0.00283	0.0451	CbGeAlD
Metoclopramide—Muscle rigidity—Naltrexone—alcohol dependence	0.00249	0.0182	CcSEcCtD
Metoclopramide—Suicide—Naltrexone—alcohol dependence	0.00246	0.018	CcSEcCtD
Metoclopramide—Trismus—Citalopram—alcohol dependence	0.00242	0.0177	CcSEcCtD
Metoclopramide—Sexual dysfunction—Acamprosate—alcohol dependence	0.0024	0.0176	CcSEcCtD
Metoclopramide—Sexual dysfunction—Naltrexone—alcohol dependence	0.00227	0.0167	CcSEcCtD
Metoclopramide—CYP11B2—adrenal cortex—alcohol dependence	0.00226	0.0361	CbGeAlD
Metoclopramide—CYP11B1—adrenal cortex—alcohol dependence	0.00226	0.0361	CbGeAlD
Metoclopramide—Tardive dyskinesia—Citalopram—alcohol dependence	0.00217	0.0159	CcSEcCtD
Metoclopramide—Feeling jittery—Citalopram—alcohol dependence	0.00217	0.0159	CcSEcCtD
Metoclopramide—Completed suicide—Naltrexone—alcohol dependence	0.00217	0.0159	CcSEcCtD
Metoclopramide—CYP11B2—cardiovascular system—alcohol dependence	0.00207	0.0329	CbGeAlD
Metoclopramide—Suicidal ideation—Acamprosate—alcohol dependence	0.00192	0.0141	CcSEcCtD
Metoclopramide—Mania—Acamprosate—alcohol dependence	0.00185	0.0136	CcSEcCtD
Metoclopramide—Suicidal ideation—Naltrexone—alcohol dependence	0.00182	0.0133	CcSEcCtD
Metoclopramide—Laryngospasm—Acamprosate—alcohol dependence	0.00181	0.0132	CcSEcCtD
Metoclopramide—HTR4—brain—alcohol dependence	0.0018	0.0287	CbGeAlD
Metoclopramide—DRD2—nerve—alcohol dependence	0.00173	0.0276	CbGeAlD
Metoclopramide—Priapism—Citalopram—alcohol dependence	0.00167	0.0122	CcSEcCtD
Metoclopramide—Hepatotoxicity—Naltrexone—alcohol dependence	0.00165	0.0121	CcSEcCtD
Metoclopramide—CYP11B2—blood—alcohol dependence	0.00163	0.0261	CbGeAlD
Metoclopramide—CYP11B1—blood—alcohol dependence	0.00163	0.0261	CbGeAlD
Metoclopramide—Erectile dysfunction—Disulfiram—alcohol dependence	0.00158	0.0116	CcSEcCtD
Metoclopramide—Muscle rigidity—Citalopram—alcohol dependence	0.00158	0.0116	CcSEcCtD
Metoclopramide—Neuroleptic malignant syndrome—Citalopram—alcohol dependence	0.00158	0.0116	CcSEcCtD
Metoclopramide—Suicide—Citalopram—alcohol dependence	0.00156	0.0114	CcSEcCtD
Metoclopramide—Drowsiness—Disulfiram—alcohol dependence	0.00153	0.0112	CcSEcCtD
Metoclopramide—Jaundice—Disulfiram—alcohol dependence	0.00149	0.0109	CcSEcCtD
Metoclopramide—Delirium—Naltrexone—alcohol dependence	0.00148	0.0109	CcSEcCtD
Metoclopramide—Menstruation irregular—Citalopram—alcohol dependence	0.00146	0.0107	CcSEcCtD
Metoclopramide—Akathisia—Citalopram—alcohol dependence	0.00146	0.0107	CcSEcCtD
Metoclopramide—Sexual dysfunction—Citalopram—alcohol dependence	0.00144	0.0106	CcSEcCtD
Metoclopramide—CYP11B2—endocrine gland—alcohol dependence	0.00142	0.0226	CbGeAlD
Metoclopramide—CYP11B1—endocrine gland—alcohol dependence	0.00142	0.0226	CbGeAlD
Metoclopramide—CYP17A1—adrenal cortex—alcohol dependence	0.00138	0.0221	CbGeAlD
Metoclopramide—Completed suicide—Citalopram—alcohol dependence	0.00137	0.0101	CcSEcCtD
Metoclopramide—Bromopride—DRD2—alcohol dependence	0.00136	0.22	CrCbGaD
Metoclopramide—Urinary incontinence—Acamprosate—alcohol dependence	0.0013	0.00953	CcSEcCtD
Metoclopramide—Breast enlargement—Citalopram—alcohol dependence	0.00125	0.00912	CcSEcCtD
Metoclopramide—Galactorrhoea—Citalopram—alcohol dependence	0.00125	0.00912	CcSEcCtD
Metoclopramide—Rash maculo-papular—Acamprosate—alcohol dependence	0.00122	0.00897	CcSEcCtD
Metoclopramide—HTR3A—brainstem—alcohol dependence	0.00121	0.0194	CbGeAlD
Metoclopramide—HTR3A—forebrain—alcohol dependence	0.00117	0.0187	CbGeAlD
Metoclopramide—Suicidal ideation—Citalopram—alcohol dependence	0.00115	0.00844	CcSEcCtD
Metoclopramide—CYP17A1—gonad—alcohol dependence	0.00115	0.0183	CbGeAlD
Metoclopramide—Mania—Citalopram—alcohol dependence	0.00111	0.00814	CcSEcCtD
Metoclopramide—Amisulpride—HTR7—alcohol dependence	0.00109	0.177	CrCbGaD
Metoclopramide—Extrapyramidal disorder—Citalopram—alcohol dependence	0.00107	0.00786	CcSEcCtD
Metoclopramide—Cardiac failure congestive—Naltrexone—alcohol dependence	0.00102	0.00747	CcSEcCtD
Metoclopramide—Atrial fibrillation—Naltrexone—alcohol dependence	0.000977	0.00715	CcSEcCtD
Metoclopramide—Delirium—Citalopram—alcohol dependence	0.000939	0.00688	CcSEcCtD
Metoclopramide—Amenorrhoea—Citalopram—alcohol dependence	0.000919	0.00673	CcSEcCtD
Metoclopramide—DRD3—nervous system—alcohol dependence	0.000919	0.0147	CbGeAlD
Metoclopramide—CHRM1—forebrain—alcohol dependence	0.000889	0.0142	CbGeAlD
Metoclopramide—DRD3—central nervous system—alcohol dependence	0.000885	0.0141	CbGeAlD
Metoclopramide—Somnolence—Disulfiram—alcohol dependence	0.000868	0.00635	CcSEcCtD
Metoclopramide—CYP17A1—endocrine gland—alcohol dependence	0.000865	0.0138	CbGeAlD
Metoclopramide—Dyskinesia—Citalopram—alcohol dependence	0.00086	0.0063	CcSEcCtD
Metoclopramide—Asthma—Acamprosate—alcohol dependence	0.000846	0.00619	CcSEcCtD
Metoclopramide—Fatigue—Disulfiram—alcohol dependence	0.000842	0.00616	CcSEcCtD
Metoclopramide—CYP17A1—testis—alcohol dependence	0.000825	0.0132	CbGeAlD
Metoclopramide—HTR3A—digestive system—alcohol dependence	0.000822	0.0131	CbGeAlD
Metoclopramide—CYP17A1—nervous system—alcohol dependence	0.00081	0.0129	CbGeAlD
Metoclopramide—Ventricular tachycardia—Citalopram—alcohol dependence	0.000808	0.00592	CcSEcCtD
Metoclopramide—Wheezing—Citalopram—alcohol dependence	0.000785	0.00575	CcSEcCtD
Metoclopramide—HTR3A—blood—alcohol dependence	0.000783	0.0125	CbGeAlD
Metoclopramide—Pollakiuria—Acamprosate—alcohol dependence	0.000781	0.00572	CcSEcCtD
Metoclopramide—CYP17A1—liver—alcohol dependence	0.00078	0.0124	CbGeAlD
Metoclopramide—Urinary incontinence—Citalopram—alcohol dependence	0.00078	0.00571	CcSEcCtD
Metoclopramide—CYP17A1—central nervous system—alcohol dependence	0.00078	0.0124	CbGeAlD
Metoclopramide—Erectile dysfunction—Acamprosate—alcohol dependence	0.000779	0.0057	CcSEcCtD
Metoclopramide—Fluid retention—Citalopram—alcohol dependence	0.000767	0.00562	CcSEcCtD
Metoclopramide—CHRM1—cardiovascular system—alcohol dependence	0.000752	0.012	CbGeAlD
Metoclopramide—Depression—Acamprosate—alcohol dependence	0.000752	0.00551	CcSEcCtD
Metoclopramide—DRD2—brainstem—alcohol dependence	0.000742	0.0118	CbGeAlD
Metoclopramide—Rash maculo-papular—Citalopram—alcohol dependence	0.000734	0.00538	CcSEcCtD
Metoclopramide—Gynaecomastia—Citalopram—alcohol dependence	0.000723	0.00529	CcSEcCtD
Metoclopramide—DRD2—forebrain—alcohol dependence	0.000716	0.0114	CbGeAlD
Metoclopramide—Amisulpride—DRD2—alcohol dependence	0.000712	0.115	CrCbGaD
Metoclopramide—Depression—Naltrexone—alcohol dependence	0.000711	0.00521	CcSEcCtD
Metoclopramide—DRD3—brain—alcohol dependence	0.000702	0.0112	CbGeAlD
Metoclopramide—Asthenia—Disulfiram—alcohol dependence	0.0007	0.00513	CcSEcCtD
Metoclopramide—Chloroprocaine—SLC6A3—alcohol dependence	0.000674	0.109	CrCbGaD
Metoclopramide—Hallucination—Acamprosate—alcohol dependence	0.000673	0.00493	CcSEcCtD
Metoclopramide—Visual impairment—Acamprosate—alcohol dependence	0.000652	0.00478	CcSEcCtD
Metoclopramide—Dizziness—Disulfiram—alcohol dependence	0.000645	0.00473	CcSEcCtD
Metoclopramide—Procaine—SLC6A3—alcohol dependence	0.000643	0.104	CrCbGaD
Metoclopramide—Hallucination—Naltrexone—alcohol dependence	0.000637	0.00467	CcSEcCtD
Metoclopramide—HTR3A—nervous system—alcohol dependence	0.000636	0.0101	CbGeAlD
Metoclopramide—CYP17A1—brain—alcohol dependence	0.000619	0.00988	CbGeAlD
Metoclopramide—Visual disturbance—Citalopram—alcohol dependence	0.000619	0.00453	CcSEcCtD
Metoclopramide—Atrial fibrillation—Citalopram—alcohol dependence	0.000619	0.00453	CcSEcCtD
Metoclopramide—Rash—Disulfiram—alcohol dependence	0.000615	0.00451	CcSEcCtD
Metoclopramide—HTR3A—central nervous system—alcohol dependence	0.000612	0.00976	CbGeAlD
Metoclopramide—Headache—Disulfiram—alcohol dependence	0.000611	0.00448	CcSEcCtD
Metoclopramide—Nervousness—Acamprosate—alcohol dependence	0.000572	0.00419	CcSEcCtD
Metoclopramide—Muscle spasms—Acamprosate—alcohol dependence	0.000566	0.00415	CcSEcCtD
Metoclopramide—Cardiac arrest—Citalopram—alcohol dependence	0.000558	0.00408	CcSEcCtD
Metoclopramide—Tremor—Acamprosate—alcohol dependence	0.000552	0.00404	CcSEcCtD
Metoclopramide—Amisulpride—HTR2A—alcohol dependence	0.00055	0.0892	CrCbGaD
Metoclopramide—Agitation—Acamprosate—alcohol dependence	0.000541	0.00396	CcSEcCtD
Metoclopramide—Nervousness—Naltrexone—alcohol dependence	0.000541	0.00396	CcSEcCtD
Metoclopramide—Angioedema—Acamprosate—alcohol dependence	0.000538	0.00394	CcSEcCtD
Metoclopramide—Muscle spasms—Naltrexone—alcohol dependence	0.000536	0.00392	CcSEcCtD
Metoclopramide—Leukopenia—Acamprosate—alcohol dependence	0.000527	0.00386	CcSEcCtD
Metoclopramide—Tremor—Naltrexone—alcohol dependence	0.000522	0.00382	CcSEcCtD
Metoclopramide—Palpitations—Acamprosate—alcohol dependence	0.000521	0.00381	CcSEcCtD
Metoclopramide—CHRM1—endocrine gland—alcohol dependence	0.000516	0.00823	CbGeAlD
Metoclopramide—Agitation—Naltrexone—alcohol dependence	0.000512	0.00375	CcSEcCtD
Metoclopramide—Convulsion—Acamprosate—alcohol dependence	0.00051	0.00374	CcSEcCtD
Metoclopramide—Angioedema—Naltrexone—alcohol dependence	0.000509	0.00373	CcSEcCtD
Metoclopramide—Hypertension—Acamprosate—alcohol dependence	0.000509	0.00373	CcSEcCtD
Metoclopramide—Asthma—Citalopram—alcohol dependence	0.000507	0.00371	CcSEcCtD
Metoclopramide—Anxiety—Acamprosate—alcohol dependence	0.0005	0.00366	CcSEcCtD
Metoclopramide—Bronchospasm—Citalopram—alcohol dependence	0.000499	0.00365	CcSEcCtD
Metoclopramide—Palpitations—Naltrexone—alcohol dependence	0.000493	0.00361	CcSEcCtD
Metoclopramide—HTR3A—brain—alcohol dependence	0.000486	0.00775	CbGeAlD
Metoclopramide—Confusional state—Acamprosate—alcohol dependence	0.000485	0.00355	CcSEcCtD
Metoclopramide—Convulsion—Naltrexone—alcohol dependence	0.000483	0.00354	CcSEcCtD
Metoclopramide—CHRM1—nervous system—alcohol dependence	0.000483	0.0077	CbGeAlD
Metoclopramide—Hypertension—Naltrexone—alcohol dependence	0.000481	0.00352	CcSEcCtD
Metoclopramide—DRD2—midbrain—alcohol dependence	0.000473	0.00754	CbGeAlD
Metoclopramide—Anxiety—Naltrexone—alcohol dependence	0.000473	0.00346	CcSEcCtD
Metoclopramide—Tachycardia—Acamprosate—alcohol dependence	0.000469	0.00344	CcSEcCtD
Metoclopramide—Pollakiuria—Citalopram—alcohol dependence	0.000468	0.00343	CcSEcCtD
Metoclopramide—Erectile dysfunction—Citalopram—alcohol dependence	0.000467	0.00342	CcSEcCtD
Metoclopramide—CHRM1—central nervous system—alcohol dependence	0.000465	0.00741	CbGeAlD
Metoclopramide—Confusional state—Naltrexone—alcohol dependence	0.000459	0.00336	CcSEcCtD
Metoclopramide—Oedema—Naltrexone—alcohol dependence	0.000455	0.00333	CcSEcCtD
Metoclopramide—Depression—Citalopram—alcohol dependence	0.000451	0.0033	CcSEcCtD
Metoclopramide—Hypotension—Acamprosate—alcohol dependence	0.000449	0.00329	CcSEcCtD
Metoclopramide—CYP2D6—brainstem—alcohol dependence	0.000446	0.00711	CbGeAlD
Metoclopramide—Tachycardia—Naltrexone—alcohol dependence	0.000444	0.00325	CcSEcCtD
Metoclopramide—Jaundice—Citalopram—alcohol dependence	0.000441	0.00323	CcSEcCtD
Metoclopramide—Insomnia—Acamprosate—alcohol dependence	0.000435	0.00318	CcSEcCtD
Metoclopramide—CYP2D6—forebrain—alcohol dependence	0.00043	0.00686	CbGeAlD
Metoclopramide—Dyspnoea—Acamprosate—alcohol dependence	0.000429	0.00314	CcSEcCtD
Metoclopramide—Somnolence—Acamprosate—alcohol dependence	0.000427	0.00313	CcSEcCtD
Metoclopramide—Cisapride—DRD2—alcohol dependence	0.000426	0.0692	CrCbGaD
Metoclopramide—Agranulocytosis—Citalopram—alcohol dependence	0.000422	0.00309	CcSEcCtD
Metoclopramide—DRD2—endocrine gland—alcohol dependence	0.000415	0.00663	CbGeAlD
Metoclopramide—Bradycardia—Citalopram—alcohol dependence	0.000413	0.00302	CcSEcCtD
Metoclopramide—Insomnia—Naltrexone—alcohol dependence	0.000411	0.00301	CcSEcCtD
Metoclopramide—Dyspnoea—Naltrexone—alcohol dependence	0.000406	0.00297	CcSEcCtD
Metoclopramide—Somnolence—Naltrexone—alcohol dependence	0.000404	0.00296	CcSEcCtD
Metoclopramide—Hallucination—Citalopram—alcohol dependence	0.000404	0.00296	CcSEcCtD
Metoclopramide—Feeling abnormal—Acamprosate—alcohol dependence	0.000396	0.0029	CcSEcCtD
Metoclopramide—DRD2—testis—alcohol dependence	0.000396	0.00632	CbGeAlD
Metoclopramide—Fatigue—Naltrexone—alcohol dependence	0.000392	0.00287	CcSEcCtD
Metoclopramide—Visual impairment—Citalopram—alcohol dependence	0.000391	0.00286	CcSEcCtD
Metoclopramide—DRD2—nervous system—alcohol dependence	0.000389	0.0062	CbGeAlD
Metoclopramide—Procainamide—CHRM2—alcohol dependence	0.000383	0.062	CrCbGaD
Metoclopramide—Urticaria—Acamprosate—alcohol dependence	0.000382	0.0028	CcSEcCtD
Metoclopramide—Body temperature increased—Acamprosate—alcohol dependence	0.00038	0.00278	CcSEcCtD
Metoclopramide—Flushing—Citalopram—alcohol dependence	0.000377	0.00276	CcSEcCtD
Metoclopramide—Feeling abnormal—Naltrexone—alcohol dependence	0.000375	0.00275	CcSEcCtD
Metoclopramide—DRD2—central nervous system—alcohol dependence	0.000374	0.00597	CbGeAlD
Metoclopramide—CHRM1—brain—alcohol dependence	0.000369	0.00589	CbGeAlD
Metoclopramide—DRD2—cerebellum—alcohol dependence	0.000366	0.00584	CbGeAlD
Metoclopramide—Urticaria—Naltrexone—alcohol dependence	0.000361	0.00265	CcSEcCtD
Metoclopramide—Body temperature increased—Naltrexone—alcohol dependence	0.00036	0.00263	CcSEcCtD
Metoclopramide—Hypersensitivity—Acamprosate—alcohol dependence	0.000354	0.00259	CcSEcCtD
Metoclopramide—Asthenia—Acamprosate—alcohol dependence	0.000345	0.00253	CcSEcCtD
Metoclopramide—Nervousness—Citalopram—alcohol dependence	0.000343	0.00251	CcSEcCtD
Metoclopramide—Muscle spasms—Citalopram—alcohol dependence	0.00034	0.00249	CcSEcCtD
Metoclopramide—Hypersensitivity—Naltrexone—alcohol dependence	0.000335	0.00245	CcSEcCtD
Metoclopramide—Tremor—Citalopram—alcohol dependence	0.000331	0.00242	CcSEcCtD
Metoclopramide—Cisapride—HTR2A—alcohol dependence	0.00033	0.0534	CrCbGaD
Metoclopramide—Diarrhoea—Acamprosate—alcohol dependence	0.000329	0.00241	CcSEcCtD
Metoclopramide—Asthenia—Naltrexone—alcohol dependence	0.000326	0.00239	CcSEcCtD
Metoclopramide—Agitation—Citalopram—alcohol dependence	0.000325	0.00238	CcSEcCtD
Metoclopramide—Angioedema—Citalopram—alcohol dependence	0.000323	0.00236	CcSEcCtD
Metoclopramide—Dizziness—Acamprosate—alcohol dependence	0.000318	0.00233	CcSEcCtD
Metoclopramide—Leukopenia—Citalopram—alcohol dependence	0.000316	0.00232	CcSEcCtD
Metoclopramide—Palpitations—Citalopram—alcohol dependence	0.000312	0.00229	CcSEcCtD
Metoclopramide—Diarrhoea—Naltrexone—alcohol dependence	0.000311	0.00228	CcSEcCtD
Metoclopramide—Convulsion—Citalopram—alcohol dependence	0.000306	0.00224	CcSEcCtD
Metoclopramide—Hypertension—Citalopram—alcohol dependence	0.000305	0.00223	CcSEcCtD
Metoclopramide—Rash—Acamprosate—alcohol dependence	0.000303	0.00222	CcSEcCtD
Metoclopramide—Dermatitis—Acamprosate—alcohol dependence	0.000303	0.00222	CcSEcCtD
Metoclopramide—CYP2D6—digestive system—alcohol dependence	0.000302	0.00482	CbGeAlD
Metoclopramide—Headache—Acamprosate—alcohol dependence	0.000301	0.00221	CcSEcCtD
Metoclopramide—Dizziness—Naltrexone—alcohol dependence	0.000301	0.0022	CcSEcCtD
Metoclopramide—Anxiety—Citalopram—alcohol dependence	0.0003	0.00219	CcSEcCtD
Metoclopramide—DRD2—brain—alcohol dependence	0.000297	0.00474	CbGeAlD
Metoclopramide—Confusional state—Citalopram—alcohol dependence	0.000291	0.00213	CcSEcCtD
Metoclopramide—Oedema—Citalopram—alcohol dependence	0.000288	0.00211	CcSEcCtD
Metoclopramide—CYP2D6—blood—alcohol dependence	0.000288	0.00459	CbGeAlD
Metoclopramide—Rash—Naltrexone—alcohol dependence	0.000287	0.0021	CcSEcCtD
Metoclopramide—Dermatitis—Naltrexone—alcohol dependence	0.000287	0.0021	CcSEcCtD
Metoclopramide—Nausea—Acamprosate—alcohol dependence	0.000286	0.00209	CcSEcCtD
Metoclopramide—Headache—Naltrexone—alcohol dependence	0.000285	0.00209	CcSEcCtD
Metoclopramide—Tachycardia—Citalopram—alcohol dependence	0.000281	0.00206	CcSEcCtD
Metoclopramide—Nausea—Naltrexone—alcohol dependence	0.00027	0.00198	CcSEcCtD
Metoclopramide—Hypotension—Citalopram—alcohol dependence	0.000269	0.00197	CcSEcCtD
Metoclopramide—Insomnia—Citalopram—alcohol dependence	0.000261	0.00191	CcSEcCtD
Metoclopramide—Dyspnoea—Citalopram—alcohol dependence	0.000257	0.00188	CcSEcCtD
Metoclopramide—Somnolence—Citalopram—alcohol dependence	0.000256	0.00188	CcSEcCtD
Metoclopramide—CYP2D6—endocrine gland—alcohol dependence	0.00025	0.00398	CbGeAlD
Metoclopramide—Fatigue—Citalopram—alcohol dependence	0.000249	0.00182	CcSEcCtD
Metoclopramide—CYP2D6—testis—alcohol dependence	0.000238	0.0038	CbGeAlD
Metoclopramide—Feeling abnormal—Citalopram—alcohol dependence	0.000238	0.00174	CcSEcCtD
Metoclopramide—CYP2D6—nervous system—alcohol dependence	0.000234	0.00373	CbGeAlD
Metoclopramide—Urticaria—Citalopram—alcohol dependence	0.000229	0.00168	CcSEcCtD
Metoclopramide—Body temperature increased—Citalopram—alcohol dependence	0.000228	0.00167	CcSEcCtD
Metoclopramide—CYP2D6—liver—alcohol dependence	0.000225	0.00359	CbGeAlD
Metoclopramide—CYP2D6—central nervous system—alcohol dependence	0.000225	0.00359	CbGeAlD
Metoclopramide—CYP2D6—cerebellum—alcohol dependence	0.00022	0.00351	CbGeAlD
Metoclopramide—Hypersensitivity—Citalopram—alcohol dependence	0.000212	0.00156	CcSEcCtD
Metoclopramide—Asthenia—Citalopram—alcohol dependence	0.000207	0.00151	CcSEcCtD
Metoclopramide—Diarrhoea—Citalopram—alcohol dependence	0.000197	0.00144	CcSEcCtD
Metoclopramide—Dizziness—Citalopram—alcohol dependence	0.000191	0.0014	CcSEcCtD
Metoclopramide—Rash—Citalopram—alcohol dependence	0.000182	0.00133	CcSEcCtD
Metoclopramide—Dermatitis—Citalopram—alcohol dependence	0.000182	0.00133	CcSEcCtD
Metoclopramide—Headache—Citalopram—alcohol dependence	0.000181	0.00132	CcSEcCtD
Metoclopramide—CYP2D6—brain—alcohol dependence	0.000179	0.00285	CbGeAlD
Metoclopramide—Nausea—Citalopram—alcohol dependence	0.000171	0.00125	CcSEcCtD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR7—alcohol dependence	5.57e-05	0.000364	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—DRD2—alcohol dependence	5.54e-05	0.000363	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—HTR7—alcohol dependence	5.54e-05	0.000363	CbGpPWpGaD
Metoclopramide—CYP2D6—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	5.52e-05	0.000361	CbGpPWpGaD
Metoclopramide—CYP2D6—Biological oxidations—CYP2E1—alcohol dependence	5.48e-05	0.000358	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—HTR2A—alcohol dependence	5.46e-05	0.000357	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—alcohol dependence	5.45e-05	0.000357	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR7—alcohol dependence	5.45e-05	0.000357	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—MAOB—alcohol dependence	5.45e-05	0.000356	CbGpPWpGaD
Metoclopramide—CYP2D6—Metapathway biotransformation—CYP2E1—alcohol dependence	5.4e-05	0.000353	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—NPY—alcohol dependence	5.4e-05	0.000353	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—PDYN—alcohol dependence	5.4e-05	0.000353	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—ALDH2—alcohol dependence	5.38e-05	0.000352	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—NPY—alcohol dependence	5.28e-05	0.000346	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—CRH—alcohol dependence	5.21e-05	0.000341	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—HTR1B—alcohol dependence	5.21e-05	0.000341	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	5.17e-05	0.000338	CbGpPWpGaD
Metoclopramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—alcohol dependence	5.16e-05	0.000337	CbGpPWpGaD
Metoclopramide—DRD3—G alpha (i) signalling events—POMC—alcohol dependence	5.12e-05	0.000335	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—OPRD1—alcohol dependence	5.11e-05	0.000334	CbGpPWpGaD
Metoclopramide—DRD3—Class A/1 (Rhodopsin-like receptors)—HTR2A—alcohol dependence	5.1e-05	0.000333	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—CRH—alcohol dependence	5.1e-05	0.000333	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—HTR1B—alcohol dependence	5.1e-05	0.000333	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—MAOB—alcohol dependence	5.1e-05	0.000333	CbGpPWpGaD
Metoclopramide—CYP2D6—Biological oxidations—GGT1—alcohol dependence	5.03e-05	0.000329	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—CRHR1—alcohol dependence	5.02e-05	0.000328	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—DRD4—alcohol dependence	4.94e-05	0.000323	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—PDYN—alcohol dependence	4.9e-05	0.000321	CbGpPWpGaD
Metoclopramide—HTR4—GPCR downstream signaling—POMC—alcohol dependence	4.8e-05	0.000314	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—CHRM2—alcohol dependence	4.72e-05	0.000309	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—CNR1—alcohol dependence	4.72e-05	0.000308	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—AVP—alcohol dependence	4.69e-05	0.000307	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—AVP—alcohol dependence	4.67e-05	0.000305	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—ALDH2—alcohol dependence	4.63e-05	0.000303	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—HTR7—alcohol dependence	4.6e-05	0.000301	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—DRD2—alcohol dependence	4.6e-05	0.000301	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—AVP—alcohol dependence	4.59e-05	0.0003	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—GOT2—alcohol dependence	4.57e-05	0.000299	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—CRHR1—alcohol dependence	4.56e-05	0.000298	CbGpPWpGaD
Metoclopramide—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—alcohol dependence	4.55e-05	0.000298	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—DRD4—alcohol dependence	4.55e-05	0.000298	CbGpPWpGaD
Metoclopramide—CYP2D6—Biological oxidations—MAOA—alcohol dependence	4.51e-05	0.000295	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—OPRK1—alcohol dependence	4.49e-05	0.000294	CbGpPWpGaD
Metoclopramide—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—alcohol dependence	4.46e-05	0.000291	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—DRD4—alcohol dependence	4.46e-05	0.000291	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	4.45e-05	0.000291	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—POMC—alcohol dependence	4.36e-05	0.000285	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—CNR1—alcohol dependence	4.35e-05	0.000284	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—OPRM1—alcohol dependence	4.33e-05	0.000283	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—ALDH2—alcohol dependence	4.33e-05	0.000283	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—OPRD1—alcohol dependence	4.31e-05	0.000282	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—CYP2E1—alcohol dependence	4.3e-05	0.000281	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—CHRM2—alcohol dependence	4.29e-05	0.00028	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—CNR1—alcohol dependence	4.25e-05	0.000278	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—HTR7—alcohol dependence	4.24e-05	0.000277	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—OPRD1—alcohol dependence	4.22e-05	0.000276	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	4.17e-05	0.000272	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—DRD2—alcohol dependence	4.15e-05	0.000271	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—HTR7—alcohol dependence	4.15e-05	0.000271	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—PDYN—alcohol dependence	4.13e-05	0.00027	CbGpPWpGaD
Metoclopramide—DRD3—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	4.07e-05	0.000266	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—PDYN—alcohol dependence	4.04e-05	0.000264	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—NPY—alcohol dependence	3.99e-05	0.000261	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—GGT1—alcohol dependence	3.95e-05	0.000258	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—GOT1—alcohol dependence	3.95e-05	0.000258	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—GOT2—alcohol dependence	3.94e-05	0.000258	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—OPRM1—alcohol dependence	3.93e-05	0.000257	CbGpPWpGaD
Metoclopramide—DRD2—G alpha (i) signalling events—POMC—alcohol dependence	3.92e-05	0.000256	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—OPRD1—alcohol dependence	3.91e-05	0.000256	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—alcohol dependence	3.9e-05	0.000255	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—HTR2A—alcohol dependence	3.88e-05	0.000254	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—AVP—alcohol dependence	3.87e-05	0.000253	CbGpPWpGaD
Metoclopramide—DRD3—Circadian rythm related genes—EP300—alcohol dependence	3.85e-05	0.000252	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—CRH—alcohol dependence	3.85e-05	0.000252	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—HTR1B—alcohol dependence	3.85e-05	0.000252	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—CRHR1—alcohol dependence	3.84e-05	0.000251	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—OPRD1—alcohol dependence	3.83e-05	0.00025	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—alcohol dependence	3.82e-05	0.00025	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—CRHR1—alcohol dependence	3.76e-05	0.000246	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—PDYN—alcohol dependence	3.75e-05	0.000245	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—CYP2E1—alcohol dependence	3.7e-05	0.000242	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—GOT2—alcohol dependence	3.68e-05	0.000241	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—PDYN—alcohol dependence	3.67e-05	0.00024	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—NPY—alcohol dependence	3.62e-05	0.000237	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—CHRM2—alcohol dependence	3.61e-05	0.000236	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—AVP—alcohol dependence	3.57e-05	0.000234	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—MAOA—alcohol dependence	3.54e-05	0.000231	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—CHRM2—alcohol dependence	3.53e-05	0.000231	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—AVP—alcohol dependence	3.49e-05	0.000229	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—HTR1B—alcohol dependence	3.49e-05	0.000228	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—CRH—alcohol dependence	3.49e-05	0.000228	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—CRHR1—alcohol dependence	3.49e-05	0.000228	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—CYP2E1—alcohol dependence	3.46e-05	0.000227	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—OPRK1—alcohol dependence	3.44e-05	0.000225	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	3.43e-05	0.000224	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—CRHR1—alcohol dependence	3.41e-05	0.000223	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—GOT1—alcohol dependence	3.4e-05	0.000222	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—GGT1—alcohol dependence	3.4e-05	0.000222	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—OPRK1—alcohol dependence	3.37e-05	0.00022	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—DRD4—alcohol dependence	3.36e-05	0.00022	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—OPRM1—alcohol dependence	3.32e-05	0.000217	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—CHRM2—alcohol dependence	3.28e-05	0.000214	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—OPRM1—alcohol dependence	3.24e-05	0.000212	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—HTR2A—alcohol dependence	3.22e-05	0.000211	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—CNR1—alcohol dependence	3.21e-05	0.00021	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—CHRM2—alcohol dependence	3.21e-05	0.00021	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—GOT1—alcohol dependence	3.18e-05	0.000208	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—GGT1—alcohol dependence	3.18e-05	0.000208	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—ADH6—alcohol dependence	3.17e-05	0.000207	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—HTR7—alcohol dependence	3.13e-05	0.000205	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—DRD2—alcohol dependence	3.13e-05	0.000205	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	3.12e-05	0.000204	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—POMC—alcohol dependence	3.1e-05	0.000203	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—DRD4—alcohol dependence	3.05e-05	0.0002	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—NPY—alcohol dependence	3.05e-05	0.0002	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	3.05e-05	0.000199	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—MAOA—alcohol dependence	3.05e-05	0.000199	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—OPRD1—alcohol dependence	3.02e-05	0.000198	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—OPRM1—alcohol dependence	3.01e-05	0.000197	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—NPY—alcohol dependence	2.99e-05	0.000195	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—HTR2A—alcohol dependence	2.97e-05	0.000194	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	2.95e-05	0.000193	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—OPRM1—alcohol dependence	2.95e-05	0.000193	CbGpPWpGaD
Metoclopramide—DRD2—Circadian rythm related genes—EP300—alcohol dependence	2.95e-05	0.000193	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—HTR1B—alcohol dependence	2.94e-05	0.000193	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—CRH—alcohol dependence	2.94e-05	0.000193	CbGpPWpGaD
Metoclopramide—CYP2D6—Biological oxidations—POMC—alcohol dependence	2.93e-05	0.000192	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—CNR1—alcohol dependence	2.92e-05	0.000191	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—HTR2A—alcohol dependence	2.91e-05	0.00019	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—PDYN—alcohol dependence	2.9e-05	0.000189	CbGpPWpGaD
Metoclopramide—CHRM1—Circadian rythm related genes—EP300—alcohol dependence	2.88e-05	0.000189	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—CRH—alcohol dependence	2.88e-05	0.000188	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—HTR1B—alcohol dependence	2.88e-05	0.000188	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—MAOA—alcohol dependence	2.85e-05	0.000186	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—DRD2—alcohol dependence	2.84e-05	0.000186	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—HTR7—alcohol dependence	2.84e-05	0.000186	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—NPY—alcohol dependence	2.77e-05	0.000181	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	2.76e-05	0.000181	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—NPY—alcohol dependence	2.71e-05	0.000177	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—WASF2—alcohol dependence	2.69e-05	0.000176	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CRHR1—alcohol dependence	2.69e-05	0.000176	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—CRH—alcohol dependence	2.67e-05	0.000175	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—HTR1B—alcohol dependence	2.67e-05	0.000175	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—AVP—alcohol dependence	2.64e-05	0.000172	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—ADH1A—alcohol dependence	2.62e-05	0.000172	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—CRH—alcohol dependence	2.62e-05	0.000171	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—HTR1B—alcohol dependence	2.62e-05	0.000171	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—WASF1—alcohol dependence	2.58e-05	0.000169	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—POMC—alcohol dependence	2.57e-05	0.000168	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—DRD4—alcohol dependence	2.57e-05	0.000168	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CHRM2—alcohol dependence	2.53e-05	0.000166	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—DRD4—alcohol dependence	2.52e-05	0.000165	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—CNR1—alcohol dependence	2.46e-05	0.000161	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—CNR1—alcohol dependence	2.4e-05	0.000157	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—HTR7—alcohol dependence	2.4e-05	0.000157	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—AVP—alcohol dependence	2.39e-05	0.000157	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—POMC—alcohol dependence	2.37e-05	0.000155	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—HTR7—alcohol dependence	2.35e-05	0.000153	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—DRD2—alcohol dependence	2.35e-05	0.000153	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—DRD4—alcohol dependence	2.34e-05	0.000153	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—OPRM1—alcohol dependence	2.32e-05	0.000152	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—POMC—alcohol dependence	2.32e-05	0.000152	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—OPRD1—alcohol dependence	2.31e-05	0.000151	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—POMC—alcohol dependence	2.3e-05	0.000151	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—DRD4—alcohol dependence	2.29e-05	0.00015	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—OPRD1—alcohol dependence	2.26e-05	0.000148	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—CNR1—alcohol dependence	2.23e-05	0.000146	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—ADH4—alcohol dependence	2.23e-05	0.000146	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—PDYN—alcohol dependence	2.22e-05	0.000145	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—HTR2A—alcohol dependence	2.19e-05	0.000143	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—CNR1—alcohol dependence	2.18e-05	0.000143	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—HTR7—alcohol dependence	2.18e-05	0.000142	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—PDYN—alcohol dependence	2.17e-05	0.000142	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—NPY—alcohol dependence	2.14e-05	0.00014	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—DRD2—alcohol dependence	2.13e-05	0.000139	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—HTR7—alcohol dependence	2.13e-05	0.000139	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—HTR1B—alcohol dependence	2.06e-05	0.000135	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CRH—alcohol dependence	2.06e-05	0.000135	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CRHR1—alcohol dependence	2.06e-05	0.000135	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—WASF2—alcohol dependence	2.06e-05	0.000135	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—AVP—alcohol dependence	2.02e-05	0.000132	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CRHR1—alcohol dependence	2.02e-05	0.000132	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—WASF2—alcohol dependence	2.02e-05	0.000132	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—HTR2A—alcohol dependence	1.99e-05	0.00013	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—POMC—alcohol dependence	1.98e-05	0.00013	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—WASF1—alcohol dependence	1.98e-05	0.000129	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—AVP—alcohol dependence	1.97e-05	0.000129	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CHRM2—alcohol dependence	1.94e-05	0.000127	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—WASF1—alcohol dependence	1.93e-05	0.000126	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—ADH7—alcohol dependence	1.9e-05	0.000124	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CHRM2—alcohol dependence	1.9e-05	0.000124	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—POMC—alcohol dependence	1.86e-05	0.000121	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—AVP—alcohol dependence	1.83e-05	0.00012	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—GGT2—alcohol dependence	1.82e-05	0.000119	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—DRD4—alcohol dependence	1.8e-05	0.000118	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—AVP—alcohol dependence	1.79e-05	0.000117	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—OPRM1—alcohol dependence	1.78e-05	0.000116	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—POMC—alcohol dependence	1.75e-05	0.000115	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—OPRM1—alcohol dependence	1.74e-05	0.000114	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CNR1—alcohol dependence	1.72e-05	0.000113	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—EP300—alcohol dependence	1.71e-05	0.000112	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—HTR7—alcohol dependence	1.68e-05	0.00011	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—DRD2—alcohol dependence	1.68e-05	0.00011	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—HTR2A—alcohol dependence	1.68e-05	0.00011	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—ADH1B—alcohol dependence	1.66e-05	0.000109	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—HTR2A—alcohol dependence	1.64e-05	0.000107	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—NPY—alcohol dependence	1.64e-05	0.000107	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—NPY—alcohol dependence	1.6e-05	0.000105	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—POMC—alcohol dependence	1.59e-05	0.000104	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CRH—alcohol dependence	1.58e-05	0.000103	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—HTR1B—alcohol dependence	1.58e-05	0.000103	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CRH—alcohol dependence	1.55e-05	0.000101	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—HTR1B—alcohol dependence	1.55e-05	0.000101	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—EP300—alcohol dependence	1.53e-05	9.99e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—HTR2A—alcohol dependence	1.52e-05	9.97e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—HTR2A—alcohol dependence	1.49e-05	9.76e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—AVP—alcohol dependence	1.41e-05	9.25e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—DRD4—alcohol dependence	1.38e-05	9.03e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—MAOB—alcohol dependence	1.38e-05	9.01e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—DRD4—alcohol dependence	1.35e-05	8.84e-05	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—POMC—alcohol dependence	1.34e-05	8.77e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CNR1—alcohol dependence	1.32e-05	8.62e-05	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—EP300—alcohol dependence	1.32e-05	8.61e-05	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—POMC—alcohol dependence	1.31e-05	8.58e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CNR1—alcohol dependence	1.29e-05	8.44e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—HTR7—alcohol dependence	1.29e-05	8.41e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—HTR7—alcohol dependence	1.26e-05	8.23e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—DRD2—alcohol dependence	1.26e-05	8.23e-05	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—EP300—alcohol dependence	1.23e-05	8.05e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—POMC—alcohol dependence	1.22e-05	7.96e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—POMC—alcohol dependence	1.19e-05	7.79e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—HTR2A—alcohol dependence	1.18e-05	7.7e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—ALDH2—alcohol dependence	1.17e-05	7.66e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—AVP—alcohol dependence	1.08e-05	7.08e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—AVP—alcohol dependence	1.06e-05	6.93e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—GOT2—alcohol dependence	9.96e-06	6.52e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—POMC—alcohol dependence	9.4e-06	6.15e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—CYP2E1—alcohol dependence	9.37e-06	6.13e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—HTR2A—alcohol dependence	9.01e-06	5.89e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—HTR2A—alcohol dependence	8.81e-06	5.76e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—GOT1—alcohol dependence	8.6e-06	5.62e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—GGT1—alcohol dependence	8.6e-06	5.62e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—MAOA—alcohol dependence	7.71e-06	5.04e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—POMC—alcohol dependence	7.19e-06	4.7e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—POMC—alcohol dependence	7.04e-06	4.6e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—EP300—alcohol dependence	6.24e-06	4.08e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—POMC—alcohol dependence	5.02e-06	3.28e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—EP300—alcohol dependence	4.77e-06	3.12e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—EP300—alcohol dependence	4.67e-06	3.05e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—EP300—alcohol dependence	3.33e-06	2.18e-05	CbGpPWpGaD
